RATIONALE: The serotonin (5-HT) system has been reported to be involved in decision-making. A key component of this neurotransmitter system is the 5-HT1A receptor, and research is beginning to show how this receptor can influence decision-making. However, this relationship has rarely been studied in humans. OBJECTIVES: This study assessed whether individual variability in 5-HT1A availability correlates with decision-making in healthy volunteers. METHODS: We measured regional availability of the 5-HT1A receptor in the hippocampal complex and striatum using positron emission tomography and correlated this with performance on two decision-making tasks measuring sensitivity to probability, rewards and punishments and temporal discounting, respectively. RESULTS: No relationship between decision-making behaviour and 5-HT1A availability in the striatum was found. However, a positive correlation was detected between participants' 5-HT1A availability in the hippocampal complex and their sensitivity to the probability of winning. Furthermore, there was a negative correlation between the degree to which participants discounted future rewards and 5-HT1A availability in the hippocampal complex. CONCLUSIONS: These data support a role for the 5-HT1A receptor in the aberrant decision-making that can occur in neuropsychiatric disorders such as depression.
RATIONALE: The serotonin (5-HT) system has been reported to be involved in decision-making. A key component of this neurotransmitter system is the 5-HT1A receptor, and research is beginning to show how this receptor can influence decision-making. However, this relationship has rarely been studied in humans. OBJECTIVES: This study assessed whether individual variability in 5-HT1A availability correlates with decision-making in healthy volunteers. METHODS: We measured regional availability of the 5-HT1A receptor in the hippocampal complex and striatum using positron emission tomography and correlated this with performance on two decision-making tasks measuring sensitivity to probability, rewards and punishments and temporal discounting, respectively. RESULTS: No relationship between decision-making behaviour and 5-HT1A availability in the striatum was found. However, a positive correlation was detected between participants' 5-HT1A availability in the hippocampal complex and their sensitivity to the probability of winning. Furthermore, there was a negative correlation between the degree to which participants discounted future rewards and 5-HT1A availability in the hippocampal complex. CONCLUSIONS: These data support a role for the 5-HT1A receptor in the aberrant decision-making that can occur in neuropsychiatric disorders such as depression.
Authors: Frederik M van der Veen; Elisabeth A T Evers; Jeroen A van Deursen; Nicolaas E P Deutz; Walter H Backes; Jeroen A J Schmitt Journal: Neuroimage Date: 2006-03-02 Impact factor: 6.556
Authors: W C Drevets; E Frank; J C Price; D J Kupfer; D Holt; P J Greer; Y Huang; C Gautier; C Mathis Journal: Biol Psychiatry Date: 1999-11-15 Impact factor: 13.382
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Alex Pine; Ben Seymour; Jonathan P Roiser; Peter Bossaerts; Karl J Friston; H Valerie Curran; Raymond J Dolan Journal: J Neurosci Date: 2009-07-29 Impact factor: 6.167
Authors: Federico E Turkheimer; Paul Edison; Nicola Pavese; Federico Roncaroli; Alexander N Anderson; Alexander Hammers; Alexander Gerhard; Rainer Hinz; Yan F Tai; David J Brooks Journal: J Nucl Med Date: 2007-01 Impact factor: 10.057
Authors: Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong Journal: Neurosci Lett Date: 2019-04-01 Impact factor: 3.046
Authors: Philipp T Neukam; Nils B Kroemer; Yacila I Deza Araujo; Lydia Hellrung; Shakoor Pooseh; Marcella Rietschel; Stephanie H Witt; Uwe Schwarzenbolz; Thomas Henle; Michael N Smolka Journal: Psychopharmacology (Berl) Date: 2018-05-05 Impact factor: 4.530
Authors: Paul Faulkner; Federico Mancinelli; Patricia L Lockwood; Mar Matarin; Raymond J Dolan; Nick W Wood; Peter Dayan; Jonathan P Roiser Journal: Int J Neuropsychopharmacol Date: 2017-01-01 Impact factor: 5.176
Authors: Paul Faulkner; Dara G Ghahremani; Rachel F Tyndale; Gerhard Hellemann; Edythe D London Journal: Int J Neuropsychopharmacol Date: 2018-09-01 Impact factor: 5.176